J.e.m. Capital (JEMC) 10-K 1 Apr 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 16, 2019	Jun. 30, 2018
Document And Entity Information
Entity Registrant Name	J.E.M. CAPITAL, INC.
Entity Central Index Key	0001537528
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	true
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		12,032,400
Entity Public Float			$ 1,249,364,200
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash	$ 164	$ 166
Deposit		550
Total current assets	164	716
Equipment, Net	496	996
Total assets	660	1,712
Current Liabilities:
Accounts payable and accrued expenses	62,875	24,459
Due to shareholder	47,945
Total Current Liabilities	110,820	24,459
Total liabilities	110,820	24,459
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $0.0001 per share, 5,000,000 shares authorized as of December 31, 2018 and December 31, 2017; none issued or outstanding as of December 31, 2018 and December 31, 2017
Common stock, $0.0001 par value; 195,000,000 shares authorized as of December 31, 2018 and 2017, 12,032,400 shares and 12,032,400 shares issued and outstanding as of December 31, 2018 and 2017	1,203	1,203
Additional paid-in capital	301,268	301,268
Accumulated deficit	(412,631)	(325,218)
Total stockholders' deficit	(110,160)	(22,747)
Total liabilities and stockholders' deficit	$ 660	$ 1,712

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Condensed Balance Sheets
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, shares authorized	195,000,000	195,000,000
Common Stock, shares issued	12,032,400	12,032,400
Common Stock, shares outstanding	12,032,400	12,032,400
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	5,000,000	5,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating expense:
General and administrative	$ 87,413	$ 160,418
Total operating expense	87,413	160,418
Loss before provision for income taxes	(87,413)	(160,418)
Provision from income taxes
Net Loss	$ (87,413)	$ (160,418)
Net loss per common share - basic and diluted	$ 0	$ 0
Weighted average number of common shares outstanding - basic and diluted	12,032,400	12,004,929

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance - Shares at Dec. 31, 2016	10,027,000
Beginning Balance - Amount at Dec. 31, 2016	$ 1,003	$ 154,097	$ (164,800)	$ (9,700)
Issued shares - shares	2,005,400
Issued shares - Amount	$ 200			200
Contribution from stockholders		147,171		147,171
Net income/loss			(160,418)	(160,418)
Ending Balance, Shares at Dec. 31, 2017	12,032,400
Ending Balance, Amount at Dec. 31, 2017	$ 1,203	301,268	(325,218)	(22,747)
Net income/loss			(87,413)	(87,413)
Ending Balance, Shares at Dec. 31, 2018	12,032,400
Ending Balance, Amount at Dec. 31, 2018	$ 1,203	$ 301,268	$ (412,631)	$ (110,160)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating Activities:
Net loss	$ (87,413)	$ (160,418)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	500	1,133
Changes in assets and liabilities
Decrease in deposit	550
Increase in accounts payable and accrued liabilities	38,416	10,096
Net cash used in operating activities	(47,947)	(149,189)
Investing activities:
Proceeds from disposal of fixed assets		2,633
Purchase of equipment		(449)
Net cash generated from investing activities		2,184
Financing activities:
Contribution from stockholders		147,171
Advance from shareholder	47,945
Net cash generated from financing activities	47,945	147,171
Net (decrease) increase in cash	(2)	166
Cash - beginning of year	166
Cash - end of year	164	166
Supplemental disclosure:
Cash paid during the year for Interest
Cash paid during the year for Income taxes

1. Organization and Principal A

1. Organization and Principal Activities	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Organization and Principal Activities	1. Organization and principal activities Nature of Operations J.E.M. Capital Inc. (the "Company") has limited operations. The Company was incorporated under the laws of the State of Delaware on September 14, 2011. On October 31, 2013, the Company entered into a Stock Purchase Agreement (the "Purchase Agreement") with Zosano Pharma Corporation, formerly known as ZP Holdings, Inc., a Delaware corporation (Zosano Pharma), pursuant to which the Company issued and sold to Zosano Pharma 10,016,973 shares of the Company common stock, $0.0001 par value, for an aggregate cash purchase price of $365,000. As a result of the issuance and sale of the Company's common stock to Zosano Pharma pursuant to the Purchase Agreement, a change in control of the Company occurred (in which Zosano Pharma acquired control of the Company). Immediately following the change in control transaction, 10,027,000 shares of the Company's Common Stock were issued and outstanding. The 10,016,973 shares of common stock issued and sold to Zosano Pharma pursuant to the Purchase Agreement represent approximately 99.9% of the Company's issued and outstanding common stock. On November 14, 2016, Zosano Phama entered into Stock Purchase Agreements with eighteen (18) foreign investors (the "New Shareholders"), pursuant to which Zosano Pharma sold an aggregate of 10,016,973 shares of common stock of Zosano, Inc. or approximately 99.9% of the issued and outstanding common stock of the Company, to the New Shareholders. On January 5, 2017, the Company entered into a Share Exchange Agreement (the "Agreement") with Essential Elements Limited, a British Virgin Islands company ("ESEL"), and Leung Chi Wah Earnest, the principal shareholder of ESEL, pursuant to which the Company issued an aggregate of 2,005,400 shares of common stock, or approximately 17% of the issued and outstanding common stock of the Company, to Mr. Leung in exchange for 100% of the issued and outstanding shares of ESEL. ESEL owns all of the issued and outstanding shares of J.E.M. Capital Limited, a company organized under the laws of Hong Kong ("JEM Capital"). ESEL and JEM Capital currently have no operations, but include the corporate structure that the Company believes necessary for the acquisition of assets in Hong Kong and China. ESEL has incurred material expenses setting up such structure.

2. Summary of Significant Accou

2. Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Risks and Uncertainties The Company's activities are subject to significant risks and uncertainties, including failure to identify a privately held operating company desiring to merge with the Company, failure to complete a reverse merger transaction, and inability to secure funding to continue as a going concern. (See Note 3 Basis of Presentation and Use of Estimates The Company's consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expense during the reporting period. Estimates are used when accounting for certain items such as accounting for income tax valuation allowances. Estimates are based on historical experience, where applicable, and assumptions that management believes are reasonable under the circumstances. Due to the inherent uncertainty involved with estimates, actual results may differ. Business acquisitions During the year ended December 31, 2017, the Company completed business acquisitions that were individually and in the aggregate insignificant. The Company has accounted for all of its acquisitions using the acquisition method. The operating results of each acquisition have been included in the consolidated financial statements since the respective dates of acquisition. There were no business acquisitions for the year ended December 31, 2018. Principles of Consolidation The consolidated financial statements include the financial statements of J.E.M Capital Inc. and its subsidiaries for which it is the primary beneficiary. Upon making this determination, the Company is deemed to be the primary beneficiary of the entity, which is then required to be consolidated for financial reporting purposes. All significant intercompany transactions and balances have been eliminated upon consolidation. Equipment, net Equipment is stated at cost less accumulated depreciation and impairment losses, if any. Depreciation is provided on a straight-line basis, less estimated residual values over the assets’ estimated useful lives. The estimated useful lives are as follows: Computer hardware and software 3 years When equipment is retired or otherwise disposed of, the related cost, accumulated depreciation and provision for impairment loss, if any, are removed from the respective accounts, and any gain or loss is reflected in the consolidated statements of operations. Repairs and maintenance costs on equipment are expensed as incurred. Impairment of Long-Lived Assets Long-lived assets, such as equipment, are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the carrying amount of a long-lived asset exceeds the sum of the undiscounted cash flows expected to be generated from the asset’s use and eventual disposition. An impairment loss is measured as the amount by which the carrying amount exceeds the fair value of the asset calculated using a undiscounted cash flow analysis. There was no impairment of long-lived assets for the years ended December 31, 2018 and 2017. Fair value of financial instruments ASC Topic 825, “Financial Instruments”, requires disclosing fair value to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheets. The fair values of the financial instruments are not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. For certain financial instruments, including deposit, accounts payable and accrued expenses, the fair values were determined based on the near term maturities of such the assets and obligations. Revenue The Company has yet to generate revenue from operations for the years ended December 31, 2018 and 2017. Net Loss per Common Share Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no dilutive financial instruments issued or outstanding for the years ended December 31, 2018 and 2017. Income Taxes The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The Company estimates the degree to which tax assets and credit carryforwards will result in a benefit based on expected profitability by tax jurisdiction. A valuation allowance for such tax assets and loss carryforwards is provided when it is determined to be more likely than not that the benefit of such deferred tax asset will not be realized in future periods. Tax benefits of operating loss carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances. If it becomes more likely than not that a tax asset will be used, the related valuation allowance on such assets would be reduced. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. Once this threshold has been met, the Company's measurement of its expected tax benefits is recognized in its consolidated financial statements. The Company accrues interest on unrecognized tax benefits as a component of income tax expense. Penalties, if incurred, would be recognized as a component of income tax expense. The Company' income tax returns are subject to examination for three years from the date filed or the due date, whichever is later. The Company did not identify any material uncertain tax positions. Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, “Leases” (“ASU 2016-02”), to make leasing activities more transparent and comparable, requiring most leases to be recognized by lessees on their balance sheets as right-of-use assets, along with corresponding lease liabilities. ASU 2016-02 is effective for annual periods beginning after December 31, 2018 and interim periods within that year, with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements as the Company does not have any lease commitments at the reporting date. In July 2017, the FASB issued ASU 2017-11 “Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”, to simplify the accounting for certain financial instruments with down round features. The amendments require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification. Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity. The amendments also address navigational concerns within the FASB Accounting Standards Codification® related to an indefinite deferral available to private companies with mandatorily redeemable financial instruments and certain noncontrolling interests, one that created significant “pending content” in the Codification. The FASB decided to reclassify the indefinite deferral as a scope exception, which does not have an accounting effect. The amendments are effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption is permitted. The Company is currently assessing the impact of ASU 2017-11 on its consolidated financial position, results of operations and cash flows. The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

3. Going Concern

3. Going Concern	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Going Concern	3. Going Concern The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern. The Company has not established any source of revenues to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of December 31, 2018, the cash resources of the Company were insufficient to continue to conduct its normal business operations. These and other factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

4. General and Administrative E

4. General and Administrative Expenses	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
General and Administrative Expenses	4. General and Administrative Expenses The Company has been engaged in activities related to the setup and formation of the company. The following summarizes the type of expenses incurred: Year Ended December 31, 2018 2017 General and administrative expense: Professional fees $ 28,466 $ 30,400 Filing fees 6,414 7,363 Franchise tax expense 409 400 Salary and related expenses 35,538 104,018 Director’s fee 12,000 - Depreciation 500 1,133 Other office expenses 4,086 17,104 Total general and administrative expense $ 87,413 $160,418

5. Stockholders' Equity

5. Stockholders' Equity	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Stockholders' Equity	5. Stockholders’ Equity Preferred Stock In September 2013, the Company adopted an amended and restated certificate of incorporation by which the Company is authorized to issue 5,000,000 shares of preferred stock with a $0.0001 par value. As of December 31, 2018, there were no shares of preferred stock issued or outstanding. Common Stock, Stock Split and Dividend In September 2013, the Company adopted an amended and restated certificate of incorporation by which the Company is authorized to issue 195,000,000 shares of common stock with a $0.0001 par value, which amended and restated certificate of incorporation went effective on October 21, 2013. In anticipation of the acquisition of the Company’s common stock by Zosano Pharma and on October 21, 2013, the Company completed a 1-for-200 reverse stock split. As a result, existing stockholders held an aggregate of 10,027 shares on a post-split basis. All share and per share amounts have been retroactively restated for the effect of this split. On October 31, 2013, the Company issued 10,016,973 shares of common stock to Zosano Pharma in exchange for an aggregate cash purchase price of $365,000. Concurrently with the receipt of the proceeds from the sale of its common stock to Zosano Pharma, the Company declared a dividend of the purchase price to its stockholders of record immediately prior to the closing of the purchase transaction. On January 5, 2017, the Company entered into a Share Exchange Agreement with Essential Elements Limited, a British Virgin Islands company (“ESEL”), and Leung Chi Wah Earnest, the principal shareholder of ESEL, pursuant to which the Company issued an aggregate of 2,005,400 shares of common stock, or approximately 17% of the issued and outstanding common stock of the Company, to Mr. Leung in exchange for 100% of the issued and outstanding shares of ESEL. ESEL owns all of the issued and outstanding shares of J.E.M. Capital Limited, a company organized under the laws of Hong Kong (“JEM Capital”). ESEL and JEM Capital currently have no operations, but include the corporate structure that the Company believes necessary for the acquisition of assets in Hong Kong and China. ESEL has incurred material expenses setting up such structure. The Company is authorized to issue 195,000,000 shares of common stock with a $0.0001 par value. As of December 31, 2018, and 2017, 12,032,400 shares and 12,032,400 shares of common stock were issued and outstanding, respectively. As of December 31, 2018, and 2017, the Company did not have any dilutive securities, such as stock options, warrants or convertible securities, issued or outstanding.

6. Due to shareholder

6. Due to shareholder	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Due to shareholder	6. Due to shareholder During year ended December 31, 2018, the Company received loan of $47,945 from its shareholder. As of December 31, 2018, the Company recorded an amount of $47,945 payable to its shareholder. The amount is unsecured, bears no interest and is repayable on demand.

7. Income Taxes

7. Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	7. Income is subject to taxation in various countries in which the Company and its subsidiaries operate or are incorporated. The loss before income taxes by geographical locations for the year ended December 31, 2018, and 2017 were summarized as follows: Year Ended December 31, 2018 2017 United States $ 46,789 $ 37,624 Foreign 40,624 122,794 $ 87,413 $ 160,418 The Company had accumulated tax losses of approximately $188,000 and $141,000 as of December 31, 2018 and 2017, respectively, which will expires between 2031 and 2037. The net operating loss carryforwards indicated above represent the principle component of the Company's deferred tax assets as of December 31, 2018 and December 31, 2017. Deferred tax assets of approximately $52,000 and $39,000 as of December 31, 2018 and December 31, 2017, respectively, will be offset by valuation allowance of the same amounts as realization of such assets is uncertain. December 31, 2018 2017 Deferred tax assets: Net operating loss carryforwards $ 52,363 $ 39,323 Total deferred tax assets 52,363 39,323 Less: Valuation allowance (52,363) (39,323) Net deferred tax assets $ - $ - Movement in valuation allowance: December 31, 2018 2017 At the beginning of the year $ 39,323 $ 55,760 Current year addition /(deduction) 13,040 (16,377) At the end of the year $ 52,363 $ 39,323 The provision for income taxes differs from the expected provision determined by applying the federal statutory rate to the income before income taxes. The reasons for the difference are state and local income taxes and various non-deductible expenses. As a result of the reduction of the corporate income tax rate from 35% to 21% due to the Tax Cuts and Jobs Act which was enacted on December 22, 2017, U.S. GAAP requires companies to remeasure their deferred tax assets and liabilities as of the date of enactment, with resulting tax effects accounted for in the period of enactment. (the change in deferred tax balances would have a corresponding change to valuation allowance thereby resulting in no income tax expense for the year).

2. Summary of Significant Acc_2

2. Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Summary Of Significant Accounting Policies Policies
Risks and Uncertainties	Risks and Uncertainties The Company's activities are subject to significant risks and uncertainties, including failure to identify a privately held operating company desiring to merge with the Company, failure to complete a reverse merger transaction, and inability to secure funding to continue as a going concern. (See Note 3
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates The Company's consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expense during the reporting period. Estimates are used when accounting for certain items such as accounting for income tax valuation allowances. Estimates are based on historical experience, where applicable, and assumptions that management believes are reasonable under the circumstances. Due to the inherent uncertainty involved with estimates, actual results may differ.
Business acquisitions	Business acquisitions During the year ended December 31, 2017, the Company completed business acquisitions that were individually and in the aggregate insignificant. The Company has accounted for all of its acquisitions using the acquisition method. The operating results of each acquisition have been included in the consolidated financial statements since the respective dates of acquisition. There were no business acquisitions for the year ended December 31, 2018.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the financial statements of J.E.M Capital Inc. and its subsidiaries for which it is the primary beneficiary. Upon making this determination, the Company is deemed to be the primary beneficiary of the entity, which is then required to be consolidated for financial reporting purposes. All significant intercompany transactions and balances have been eliminated upon consolidation.
Equipment, net	Equipment, net Equipment is stated at cost less accumulated depreciation and impairment losses, if any. Depreciation is provided on a straight-line basis, less estimated residual values over the assets’ estimated useful lives. The estimated useful lives are as follows: Computer hardware and software 3 years When equipment is retired or otherwise disposed of, the related cost, accumulated depreciation and provision for impairment loss, if any, are removed from the respective accounts, and any gain or loss is reflected in the consolidated statements of operations. Repairs and maintenance costs on equipment are expensed as incurred.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets, such as equipment, are reviewed for impairment whenever events or changes in circumstance indicate that the carrying amount of the assets may not be recoverable. An impairment loss is recognized when the carrying amount of a long-lived asset exceeds the sum of the undiscounted cash flows expected to be generated from the asset’s use and eventual disposition. An impairment loss is measured as the amount by which the carrying amount exceeds the fair value of the asset calculated using a undiscounted cash flow analysis. There was no impairment of long-lived assets for the years ended December 31, 2018 and 2017.
Fair value of financial instruments	Fair value of financial instruments ASC Topic 825, “Financial Instruments”, requires disclosing fair value to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheets. The fair values of the financial instruments are not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. For certain financial instruments, including deposit, accounts payable and accrued expenses, the fair values were determined based on the near term maturities of such the assets and obligations.
Revenue	Revenue The Company has yet to generate revenue from operations for the years ended December 31, 2018 and 2017.
Net Loss per Common Share	Net Loss per Common Share Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no dilutive financial instruments issued or outstanding for the years ended December 31, 2018 and 2017.
Income Taxes	Income Taxes The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The Company estimates the degree to which tax assets and credit carryforwards will result in a benefit based on expected profitability by tax jurisdiction. A valuation allowance for such tax assets and loss carryforwards is provided when it is determined to be more likely than not that the benefit of such deferred tax asset will not be realized in future periods. Tax benefits of operating loss carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances. If it becomes more likely than not that a tax asset will be used, the related valuation allowance on such assets would be reduced. The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. Once this threshold has been met, the Company's measurement of its expected tax benefits is recognized in its consolidated financial statements. The Company accrues interest on unrecognized tax benefits as a component of income tax expense. Penalties, if incurred, would be recognized as a component of income tax expense. The Company' income tax returns are subject to examination for three years from the date filed or the due date, whichever is later. The Company did not identify any material uncertain tax positions.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, “Leases” (“ASU 2016-02”), to make leasing activities more transparent and comparable, requiring most leases to be recognized by lessees on their balance sheets as right-of-use assets, along with corresponding lease liabilities. ASU 2016-02 is effective for annual periods beginning after December 31, 2018 and interim periods within that year, with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements as the Company does not have any lease commitments at the reporting date. In July 2017, the FASB issued ASU 2017-11 “Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”, to simplify the accounting for certain financial instruments with down round features. The amendments require companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for purposes of determining liability or equity classification. Companies that provide earnings per share (EPS) data will adjust their basic EPS calculation for the effect of the feature when triggered (i.e., when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity. The amendments also address navigational concerns within the FASB Accounting Standards Codification® related to an indefinite deferral available to private companies with mandatorily redeemable financial instruments and certain noncontrolling interests, one that created significant “pending content” in the Codification. The FASB decided to reclassify the indefinite deferral as a scope exception, which does not have an accounting effect. The amendments are effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption is permitted. The Company is currently assessing the impact of ASU 2017-11 on its consolidated financial position, results of operations and cash flows. The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

4. General and Administrative_2

4. General and Administrative Expenses (Tables)	12 Months Ended
	Dec. 31, 2018
General And Administrative Expenses Tables
Summary of general and administrative expense	The Company has been engaged in activities related to the setup and formation of the company. The following summarizes the type of expenses incurred: Year Ended December 31, 2018 2017 General and administrative expense: Professional fees $ 28,466 $ 30,400 Filing fees 6,414 7,363 Franchise tax expense 409 400 Salary and related expenses 35,538 104,018 Director’s fee 12,000 - Depreciation 500 1,133 Other office expenses 4,086 17,104 Total general and administrative expense $ 87,413 $160,418

7. Income Taxes (Tables)

7. Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Loss before income taxes by geographical locations	The loss before income taxes by geographical locations for the year ended December 31, 2018, and 2017 were summarized as follows: Year Ended December 31, 2018 2017 United States $ 46,789 $ 37,624 Foreign 40,624 122,794 $ 87,413 $ 160,418
Components of the Company's deferred tax assets	Deferred tax assets of approximately $52,000 and $39,000 as of December 31, 2018 and December 31, 2017, respectively, will be offset by valuation allowance of the same amounts as realization of such assets is uncertain. December 31, 2018 2017 Deferred tax assets: Net operating loss carryforwards $ 52,363 $ 39,323 Total deferred tax assets 52,363 39,323 Less: Valuation allowance (52,363) (39,323) Net deferred tax assets $ - $ -
Movement in valuation allowance	Movement in valuation allowance: December 31, 2018 2017 At the beginning of the year $ 39,323 $ 55,760 Current year addition /(deduction) 13,040 (16,377) At the end of the year $ 52,363 $ 39,323

1. Organization and Principal_2

1. Organization and Principal Activities (Details Narrative)	Oct. 31, 2013$ / sharesshares
Accounting Policies [Abstract]
Number of shares issued for purchase of company | shares	10,016,973
Price per share | $ / shares	$ 0.0001
Percent of stock owned after issuance	99.90%

2. Summary of Significant Acc_3

2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Notes to Financial Statements
Computer hardware and software useful life	3 years
Impairment of long-lived assets	$ 0	$ 0

4. General and Administrative_3

4. General and Administrative Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
General and administrative expense:
Professional fees	$ 28,466	$ 30,400
Filing fees	6,414	7,363
Franchise tax expense	409	400
Salary and related expenses	35,538	104,018
Director's fee	12,000
Depreciation	500	1,133
Other office expenses	4,086	17,104
Total general and administrative expenses	$ 87,413	$ 160,418

5. Stockholders' Equity (Detail

5. Stockholders' Equity (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018
Stockholders Equity Details Narrative
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares Issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock shares authorized	195,000,000	195,000,000
Common stock shares issued	12,032,400	12,032,400
Common stock shares outstanding	12,032,400	12,032,400
Common stock held by stockholder	10,016,973	10,016,973
Purchase Price		$ 365,000
Reverse stock split	1-for-200
Post-split basis	10,027

6. Due to shareholder (Details

6. Due to shareholder (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Notes to Financial Statements
Advance from shareholder	$ 47,945
Due to shareholder	$ 47,945

7. Income Taxes - Loss before i

7. Income Taxes - Loss before income taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
United States	$ 46,789	$ 37,624
Foreign	40,624	122,794
Loss before income taxes	$ 87,413	$ 160,418

7. Income Taxes - Components of

7. Income Taxes - Components of the Company's deferred tax assets (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Deferred tax assets:
Net operating loss carryforwards	$ 52,363	$ 39,323
Total deferred tax assets	52,363	39,323
Less: Valuation allowance	(52,363)	(39,323)
Net deferred tax assets

7. Income Taxes - Movement in V

7. Income Taxes - Movement in Valuation Allowance (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
At the beginning of the year	$ 39,323	$ 55,760
Current year (deduction)/addition	13,040	(16,377)
At the end of the year	$ 52,363	$ 39,323

7. Income Taxes (Details Narrat

7. Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Approximate federal income tax net operating loss carryforwards	$ 188,000	$ 141,000
Deferred tax assets	$ 52,363	$ 39,323
Income tax rate	21.00%	21.00%
Minimum [Member]
Operating loss carryforwards expiration date	Jan. 1, 2031
Maximum [Member]
Operating loss carryforwards expiration date	Dec. 31, 2037